3.50
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
13.55
|
- | 7.904 | 14.97 | 10.85 |
Operating Income/Loss |
54.89%
-13.55
|
-8.748 | -7.904 | -14.97 | -10.85 |
Nonoperating Income/Loss |
249.64%
2.695
|
-1.801 | 2.898 | 1.935 | 0.876 |
Income/Loss From Continuing Operations Before Tax |
2.90%
-10.86
|
-10.55 | -5.006 | -13.03 | -9.977 |
Income Tax Expense/Benefit |
170.73%
0.029
|
-0.041 | 0.009 | -0.025 | 0.025 |
Income/Loss From Continuing Operations After Tax |
3.58%
-10.88
|
-10.51 | -5.015 | -13.01 | -10.00 |
|
3.58%
-10.88
|
-10.51 | -5.015 | -13.01 | -10.00 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.69M%
30.49
|
0.0018 | 30.47 | 30.46 | 30.44 |
Basic Earnings Per Share |
5.88%
-0.36
|
-0.34 | -0.16 | -0.43 | -0.33 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):